Federal Spending on Off-Patent Drugs That Lack Generic Competition

被引：5
作者：
Rome, Benjamin N. [1 ,2 ]
Kesselheim, Aaron S. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
来源：
JOURNAL OF GENERAL INTERNAL MEDICINE | 2021年 / 36卷 / 03期
关键词：
D O I：
10.1007/s11606-020-05752-y
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：821 / 823
页数：3
相关论文
共 50 条
  • [31] The Off-Patent Biological Market in Belgium: Is the Health System Creating a Hurdle to Fair Market Competition?
    Van Wilder, Philippe
    PHARMACEUTICALS, 2021, 14 (04)
  • [32] Impacts of tendering for off-patent medicines on access and costs
    Vogler, S.
    Gombocz, M.
    Zimmermann, N.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2016, 26 : 137 - 137
  • [33] BIG-3 HEAD DOWN THE GENERICS ROAD - SEEKING GROWTH IN OFF-PATENT DRUGS
    YOUNG, I
    CHEMICAL WEEK, 1995, 156 (20) : 40 - 42
  • [34] EXCESSIVE PRICING OF OFF-PATENT PHARMACEUTICALS: HATCH IT OR RATCHET?
    Graber, Jennifer L.
    NEW YORK UNIVERSITY LAW REVIEW, 2017, 92 (04) : 1146 - 1186
  • [35] Companies use value-based pricing for single-source off-patent drugs
    Thompson, Cheryl A.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (06) : 350 - +
  • [36] Copyright protection of software in an off-patent medical device: Is it extending a patent monopoly?
    Johnson, L
    BIOTECHNOLOGY LAW REPORT, 2001, 20 (04) : 537 - 545
  • [37] A MULTI-CRITERIA DECISION ANALYSIS (MCDA) TOOL FOR PURCHASING OFF-PATENT ONCOLOGY DRUGS IN EGYPT
    Elezbawy, B.
    Fasseeh, A. N.
    Eldessouki, R.
    Kirollos, M. G.
    Eldebeiky, M.
    Sedrak, A. S.
    Amer, H.
    Elnashar, S. A. A.
    Morsy, A.
    Amin, A. A.
    Saad, A. S.
    Abaza, S.
    Kalo, Z.
    VALUE IN HEALTH, 2022, 25 (01) : S170 - S170
  • [38] Addressing the Lack of Competition in Generic Drugs to Improve Healthcare Quality and Safety
    Sivashanker, Karthik
    Fanikos, John
    Kachalia, Allen
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (11) : 2005 - 2007
  • [39] Addressing the Lack of Competition in Generic Drugs to Improve Healthcare Quality and Safety
    Karthik Sivashanker
    John Fanikos
    Allen Kachalia
    Journal of General Internal Medicine, 2018, 33 : 2005 - 2007
  • [40] Off-Patent Medicines Policies in the Quest for Value in Global Healthcare
    Applied Health Economics and Health Policy, 2015, 13 (Suppl 1) : 1 - 1
12345